Song, Z., Li, R. (2025). Eribulin plus pyrotinib In trastuzumab-resistant HER2-positive advanced breast cancer: A single-arm, multicenter phase II trial (EPIC trial).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.1031